13F

Stock

Atara Biotherapeutics, Inc.

ATRA · held by 41 managers

Reported value

$35.7M

Holders

41

+0 new · −0 exited

Holders’ est. mark

$82.1K

Price effect on 2 books still in the name

Largest holder

$10.4M

EcoR1 Capital, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
EcoR1 Capital, LLC573.2K$10.4M—Held
Redmile Group, LLC441.7K$7.99M—Held
Vanguard225.9K$4.09M—Held
MARSHALL WACE, LLP148.6K$2.69M—Held
GLOBEFLEX CAPITAL L P77.2K$1.4M—Held
BlackRock, Inc.67.1K$1.21M—Held
GEODE CAPITAL MANAGEMENT, LLC62.4K$1.13M—Held
MACKENZIE FINANCIAL CORP58.7K$1.05M—Held
STALEY CAPITAL ADVISERS INC50K$904.5K—Held
BRIDGEWAY CAPITAL MANAGEMENT, LLC32.7K$591.4K—Held
Renaissance Technologies30K$543.4K—Held
State Street26.5K$478.5K—Held
Quadrature Capital Ltd20.3K$367.6K—Held
Point72 Asset Management, L.P.18.3K$331K—Held
Fidelity17.2K$310.4K—Held
MORGAN STANLEY16K$289.3K$60.1KCut−$225.7K
Citadel15.6K$281.8K—Held
SUSQUEHANNA INTERNATIONAL GROUP, LLP14K$253.6K—Held
JANE STREET GROUP, LLC14K$253.1K—Held
NORTHERN TRUST CORP12.3K$223.2K—Held
Walleye Capital LLC12.2K$220.1K—Held
Connor, Clark & Lunn Investment Management Ltd.10.4K$189K—Held
BANK OF AMERICA CORP /DE/10.4K$187.9K$22KAdded$104.1K
DIMENSIONAL FUND ADVISORS LP10K$181.4K—Held
Tower Research Capital LLC (TRC)1.74K$31.4K—Held
SBI Securities Co., Ltd.1.4K$25.4K—Held
UBS Group AG1.4K$25.3K—Held
Private Wealth Asset Management, LLC900$16.3K—Held
ROYAL BANK OF CANADA850$15K—Held
JONES FINANCIAL COMPANIES LLLP703$12.7K—Held
WELLS FARGO & COMPANY/MN251$4.54K—Held
JPMORGAN CHASE & CO216$3.91K—Held
Banque Transatlantique SA176$3.18K—Held
RHUMBLINE ADVISERS175$3.17K—Held
FEDERATED HERMES, INC.130$2.35K—Held
ACADIAN ASSET MANAGEMENT LLC54K$976—Held
BNP PARIBAS FINANCIAL MARKETS46$832—Held
Cambridge Investment Research Advisors, Inc.22.9K$414—Held
OSAIC HOLDINGS, INC.10$180—Held
Rockefeller Capital Management L.P.8$145—Held
KERR FINANCIAL PLANNING Corp24$112—Held

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.